In our study, reduced neurogenesis in AD mice was prevented by Ctsb treatment, possibly by modulation of gene expression and protein activity within the neurogenic niche (Niklison‐Chirou et al. 2020). The gene discussed is CTSB; the disease is Alzheimer disease.